Candriam Equities L Oncology Impact C
LU1864484214
Candriam Equities L Oncology Impact C/ LU1864484214 /
| NAV23/01/2025 |
Var.+2.5400 |
Type of yield |
Focus sugli investimenti |
Società d'investimento |
| 238.7100EUR |
+1.08% |
reinvestment |
Equity
Worldwide
|
Candriam ▶ |
Investment strategy
Equities of companies in the field of oncology (cancer research, diagnosis, treatment, etc.) whose registered offices and/or principal activities are throughout the world.
The fund seeks to achieve capital growth by investing in the principal assets traded and to outperform the benchmark while also generating a positive social impact over the long term, by selecting companies that address certain societal challenges and mobilise resources in the fight against cancer. The management team makes discretionary investment choices based on economic/financial analyses, but also on the basis of Candriam's internal analysis of environmental, social and governance (ESG) criteria.
Investment goal
Equities of companies in the field of oncology (cancer research, diagnosis, treatment, etc.) whose registered offices and/or principal activities are throughout the world.
Dati master
| Type of yield: |
reinvestment |
| Fondi Categoria: |
Equity |
| Region: |
Worldwide |
| Settore: |
Sector Health / Pharma |
| Benchmark: |
MSCI World (Net Return) |
| Business year start: |
01/01 |
| Ultima distribuzione: |
- |
| Banca depositaria: |
CACEIS Bank, Luxembourg Branch |
| Domicilio del fondo: |
Luxembourg |
| Permesso di distribuzione: |
Austria, Germany, Switzerland, Czech Republic |
| Gestore del fondo: |
Rudi Van Den Eynde, Linden Thomson |
| Volume del fondo: |
1.89 bill.
USD
|
| Data di lancio: |
25/04/2019 |
| Investment focus: |
- |
Condizioni
| Sovrapprezzo emissione: |
3.50% |
| Tassa amministrativa massima: |
1.60% |
| Investimento minimo: |
0.00 EUR |
| Deposit fees: |
- |
| Redemption charge: |
0.00% |
| Prospetto semplificato: |
Download (Print version) |
Società d'investimento
| Funds company: |
Candriam |
| Indirizzo: |
19-21 route d'Arlon, 8009, Strassen |
| Paese: |
Luxembourg |
| Internet: |
www.candriam.com
|
Attività
| Stocks |
|
96.74% |
| Cash |
|
2.75% |
| Altri |
|
0.51% |
Paesi
| United States of America |
|
57.17% |
| Switzerland |
|
11.53% |
| Germany |
|
8.29% |
| Denmark |
|
6.57% |
| United Kingdom |
|
5.04% |
| Japan |
|
2.83% |
| Cash |
|
2.75% |
| Cayman Islands |
|
2.24% |
| Netherlands |
|
1.25% |
| Ireland |
|
1.20% |
| China |
|
0.62% |
| Altri |
|
0.51% |
Filiali
| Pharma/Biotechnology |
|
71.34% |
| Healthcare services |
|
15.04% |
| Healthcare appliances |
|
10.36% |
| Cash |
|
2.75% |
| Altri |
|
0.51% |